Pharmacists in Saukville, WI Accepting Medicare
10 Pharmacists found. Showing 1 - 10
 Dr. Jonathan Foust, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 829 E Green Bay Ave, Saukville, WI 53080 Phone: 262-268-9091 |
Mr. Cary Joseph Rothman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 829 E Green Bay Ave, Saukville, WI 53080 Phone: 262-268-9091 |
Dr. Benjamin William Mattila, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 825 E Green Bay Ave, Saukville, WI 53080 Phone: 262-284-9881 Fax: 262-284-1174 |
Matthew D Weege, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 829 E Green Bay Ave, Saukville, WI 53080 Phone: 262-268-9091 Fax: 262-268-9098 |
 Mrs. Toby Lynn Capaul, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 829 E Green Bay Ave, Saukville, WI 53080 Phone: 262-268-9091 Fax: 262-268-9098 |
Ms. Kerri Lynn Garant, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Walmart Pharmacy 10-1650, 825 E. Green Bay Avenue, Saukville, WI 53080 Phone: 262-284-9881 Fax: 262-284-1174 |
Luke William Schueller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 825 E Green Bay Ave, Saukville, WI 53080 Phone: 262-284-9881 |
Susan Annette Goethel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 825 E Green Bay Ave, Saukville, WI 53080 Phone: 262-284-9881 Fax: 262-284-1174 |
David Grandinetti Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 829 E Green Bay Ave, Saukville, WI 53080 Phone: 262-268-9091 |
Gina Lynn Lusis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 825 E Green Bay Ave, Saukville, WI 53080 Phone: 262-284-9881 Fax: 262-284-1174 |
News Archive
YM BioSciences initiates enrollment in nimotuzumab trial in brain metastases from NSCLC
YM BioSciences Inc., today announced that the first US patient has been enrolled in its randomized, double-blind trial evaluating nimotuzumab in patients with brain metastases from NSCLC at the Florida Cancer Institute - New Hope. This trial initiation follows recent clearance from the US FDA announced on January 26, 2010 allowing the Company to enroll patients at US clinical sites for two of its international and ongoing randomized, double-blind Phase II trials of nimotuzumab.
Scientists provide specific recommendations to reduce health risks for beachgoers
Beach sand contains all kinds of microorganisms, including those that can harm human health. Yet current guidelines are focused exclusively on monitoring the levels of microbes in the water.
NeuroMetrix to introduce NC-stat DPNCheck device for diabetic peripheral neuropathy
NeuroMetrix, Inc. announced today that it expects to meet its planned launch date for its latest product, NC-stat|DPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy.
HCCMIS adds Coventry National Network to enhance health-care provider network
HCC Medical Insurance Services, LLC, a provider of worldwide medical insurance, has enhanced their health-care provider network by adding the Coventry National Network, through First Health.
› Verified 1 days ago
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists